Evidence map›Paper›PMID 39930930›Full record

ArticleJournal of neurochemistry2025

Direct Current Stimulation (DCS) Modulates Lipid Metabolism and Intercellular Vesicular Trafficking in SHSY-5Y Cell Line: Implications for Parkinson's Disease.

Marco Piccoli, Luisa Barbato, Natale Vincenzo Maiorana, Alessandra Mingione, Francesca Raimondo, Marco Ghirimoldi, Federica Cirillo, Mattia Schiepati, Domenico Salerno, Luigi Anastasia and 5 more

Abstract read
In one paragraph

Article in Journal of neurochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Marco PiccoliInstitute for Molecular and Translational Cardiology (IMTC), IRCCS Policlinico San Donato, Milan, Italy.
Luisa BarbatoBiochemistry Laboratory, IRCCS Policlinico San Donato, Milan, Italy.ORCID 0009-0001-5029-679X
Natale Vincenzo Maiorana"Aldo Ravelli" Research Centre, Department of Health Sciences, University of Milan, Milan, Italy.
Alessandra Mingione"Aldo Ravelli" Research Centre, Department of Health Sciences, University of Milan, Milan, Italy.
Francesca RaimondoSchool of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
Marco GhirimoldiBiological Mass Spectrometry Lab, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Federica CirilloInstitute for Molecular and Translational Cardiology (IMTC), IRCCS Policlinico San Donato, Milan, Italy.
Mattia Schiepati"Aldo Ravelli" Research Centre, Department of Health Sciences, University of Milan, Milan, Italy.
Domenico SalernoSchool of Medicine and Surgery BioNanoMedicine Center NANOMIB, University of Milan-Bicocca, Monza, Italy.
Luigi AnastasiaInstitute for Molecular and Translational Cardiology (IMTC), IRCCS Policlinico San Donato, Milan, Italy.
Elisabetta AlbiDepartment of Pharmaceutical Sciences, Interno Orto Botanico, University of Perugia, Perugia, Italy.
Marcello ManfrediInstitute for Molecular and Translational Cardiology (IMTC), IRCCS Policlinico San Donato, Milan, Italy.
Tommaso Bocci"Aldo Ravelli" Research Centre, Department of Health Sciences, University of Milan, Milan, Italy.
Alberto Priori"Aldo Ravelli" Research Centre, Department of Health Sciences, University of Milan, Milan, Italy.
Paola SignorelliBiochemistry Laboratory, IRCCS Policlinico San Donato, Milan, Italy.

Funding

Aging Project Department of Excellence Dimet, UniPOAldo Ravelli Centre for Neurotechnology and Brain Therapeutics, Department Health Sciences, UniMI
6 · The paper itself

Abstract

The modulation of the brain's electrical activity for therapeutic purposes has recently gained attention, supported by the promising results obtained through the non-invasive application of transcranial direct current stimulation (tDCS) in the treatment of neurodegenerative and neurological diseases. To optimize therapeutic efficacy, it is crucial to investigate the cellular and molecular effects of tDCS. This will help to identify important biomarkers, predict patient's response and develop personalized treatments. In this study, we applied direct current stimulation (DCS) to a neural cell line, using mild currents over short periods of time (0.5 mA, 20 min), with 24-h intervals. We observed that DCS induced changes in the cellular lipidome, with transient effects observed after a single stimulation (lasting 24 h) and more significant, long-lasting effects (up to 72 h) after repeated stimulation cycles. In neural cells, multiple DCS treatment modulated structural membrane lipids (PE, PS, PI), downregulated glycerol lipids with ether-linked fatty acids and pro-inflammatory lipids (ceramides and lyso-glycerophospholipids) (p ≤ 0.005). Multiple DCS sessions altered transcriptional activity by decreasing the expression of inflammatory cytokines (TNF-α, p ≤ 0.05; IL-1β, p ≤ 0.01), while increasing the expression of neuroprotective factors such as heme oxygenase-1 (p ≤ 0.0001) and brain-derived neurotrophic factor (p ≤ 0.05), as well as proteins involved in vesicular transport (SNARE, sorting nexins and seipin and α-synuclein; p ≤ 0.05). In addition, DCS enhanced the release of extracellular vesicles, with repeated stimulations significantly increasing the release of exosomes threefold. In conclusion, while a single electrical stimulation induces transient metabolic changes with limited phenotypic effects, repeated applications induce a broader and deeper modulation of lipid species. This may lead to a neuroprotective and neuroplasticity-focussed transcriptional profile, potentially supporting the therapeutic effects of tDCS at the cellular and molecular level in patients..

Indexed as

Extracellular VesiclesLipid MetabolismParkinson DiseaseTranscranial Direct Current StimulationCell Line, TumorHumansdirect current stimulation (DCS)extracellular vesiclesinflammationlipidsneurodegenerationneuroplasticity

Identifiers

PMID39930930
PMCPMC11811683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.